-
1
المؤلفون: Martha Nance, Izelle Labuschagne, Karen Marder, C. Herd, Mays A. El-Dairi, Scott R. Evans, A. Daley, Henry Moore, Phyllis Chua, Jody Corey-Bloom, S. Targum, Patrick Mitchell, Jody Goldstein, David Ames, Rajeev Ananda Kumar, H. Mack, Eric Molho, S. Wray, Susan R. Criswell, Carlos Singer, Ronda Clouse, Anita M.Y. Goh, Karen Anderson, Andrew Feigin, David Oakes, Jane Griffith, Peter K. Panegyres, Carr J. Vaughan, Alessandro Iannaccone, Andrew Churchyard, Leah Levi, Craig W. Ritchie, Russell L. Margolis, D. L. Lim, Nadine Yoritomo, Barbara J. Jennings, Cameron Stone, Vicki Sergo, Constance Orme, Sarah Janicki, D. Angus, K. Helles, H. D. Rosas, Ralf Reilmann, Carolyn M. Drazinic, Arthur Watts, B. Hennig, Shea Gluhm, Sharon Fekrat, Sandra K. Kostyk, Earl Ray Dorsey, M. Moscovitch-Lopatin, Mark S. LeDoux, S. Gao, R. Ranzi, N. Padron, Elise Kayson, Shannon Guyot, K. Baker, Pinky Agarwal, Clement T. Loy, Marguerite Wieler, Steven M. Hersch, Cindy Casaceli, M. Murathodizic, Julie C. Stout, Blair R. Leavitt, D. Germaine
المصدر: The Lancet. Neurology. 14(1)
مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Population, Trail Making Test, Placebo-controlled study, Placebo, Placebos, Huntington's disease, Double-Blind Method, Internal medicine, medicine, Humans, education, Adverse effect, education.field_of_study, business.industry, Montreal Cognitive Assessment, Clioquinol, Middle Aged, medicine.disease, Huntington Disease, Treatment Outcome, Tolerability, Female, Neurology (clinical), business, Cognition Disorders, Biomarkers
-
2دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.